BioSig Technologies Announces Board Changes
Ticker: STEX · Form: 8-K · Filed: May 21, 2024 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | May 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, board-changes, officer-compensation
TL;DR
BioSig board shake-up: director out, new one in, comp plans updated.
AI Summary
BioSig Technologies, Inc. announced on May 20, 2024, a change in its board of directors. Specifically, the company reported the departure of a director and the election of a new director, along with updates to its compensatory arrangements for certain officers.
Why It Matters
Changes in a company's board of directors can signal shifts in strategy, governance, or investor relations.
Risk Assessment
Risk Level: low — This filing reports routine corporate governance changes and does not involve significant financial transactions or operational shifts.
Key Players & Entities
- BioSig Technologies, Inc. (company) — Registrant
- May 20, 2024 (date) — Date of earliest event reported
FAQ
Who departed from the BioSig Technologies, Inc. board of directors?
The filing indicates the departure of a director, but does not name the individual in the provided text.
Was a new director elected to the board?
Yes, the filing states that a new director was elected.
What other information is included regarding officer compensation?
The filing mentions updates to the compensatory arrangements of certain officers.
What is the principal executive office address for BioSig Technologies, Inc.?
The principal executive offices are located at 55 Greens Farms Road, 1st Floor, Westport, Connecticut 06880.
What is the filing date for this Form 8-K?
This Form 8-K was filed as of May 21, 2024.
Filing Stats: 523 words · 2 min read · ~2 pages · Grade level 13.3 · Accepted 2024-05-21 11:08:38
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BSGM The NASDAQ Capital M
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-24-020836.txt ( ) — 205KB
- bsgm-20240520.xsd (EX-101.SCH) — 3KB
- bsgm-20240520_lab.xml (EX-101.LAB) — 33KB
- bsgm-20240520_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSIG TECHNOLOGIES, INC. Date: May 21, 2024 By: /s/ Anthony Amato Name: Anthony Amato Title: Chief Executive Officer